Article
Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.
BMC neurology - 25 Jul 2011
Kiyohara Chikako, Miyake Yoshihiro, Koyanagi Midori, Fujimoto Takahiro, Shirasawa Senji, Tanaka Keiko, Fukushima Wakaba, Sasaki Satoshi, Tsuboi Yoshio, Yamada Tatsuo, Oeda Tomoko, Shimada Hiroyuki, Kawamura Nobutoshi, Sakae Nobutaka, Fukuyama Hidenao, Hirota Yoshio, Nagai Masaki
Abstract excerpt
BACKGROUND: Parkinson's disease (PD) is characterized by alterations in dopaminergic neurotransmission. Genetic polymorphisms involved in dopaminergic neurotransmission may influence susceptibility to PD. METHODS: We investigated the relationship of catechol-O-methyltransferase (COMT), monoamine oxidase B (MAOB), dopamine receptor (DR) D2 and DRD4 polymorphisms and PD risk with special attention to the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
